INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,564,000 | -44.2% | 1,518,465 | -2.5% | 0.00% | -100.0% |
| Q2 2019 | $2,804,000 | -4.2% | 1,557,560 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $2,928,000 | +59.3% | 1,557,560 | 0.0% | 0.00% | – |
| Q4 2018 | $1,838,000 | -56.5% | 1,557,560 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $4,221,000 | +38.3% | 1,557,560 | -2.5% | 0.00% | 0.0% |
| Q2 2018 | $3,053,000 | -3.8% | 1,598,309 | +5.8% | 0.00% | 0.0% |
| Q1 2018 | $3,172,000 | +161.7% | 1,510,309 | +153.0% | 0.00% | – |
| Q4 2017 | $1,212,000 | -81.8% | 597,030 | -88.1% | 0.00% | -100.0% |
| Q3 2017 | $6,672,000 | -9.9% | 5,015,716 | +6.4% | 0.00% | 0.0% |
| Q2 2017 | $7,401,000 | -49.8% | 4,714,107 | +3.2% | 0.00% | -50.0% |
| Q1 2017 | $14,748,000 | +150.7% | 4,565,947 | +4.8% | 0.00% | +300.0% |
| Q4 2016 | $5,883,000 | -13.2% | 4,358,071 | +0.3% | 0.00% | -50.0% |
| Q3 2016 | $6,778,000 | +84.4% | 4,344,581 | +57.2% | 0.00% | +100.0% |
| Q2 2016 | $3,676,000 | -74.7% | 2,763,429 | +0.2% | 0.00% | -75.0% |
| Q1 2016 | $14,532,000 | -13.3% | 2,757,662 | +29.1% | 0.00% | 0.0% |
| Q4 2015 | $16,762,000 | -18.2% | 2,135,322 | -11.9% | 0.00% | -33.3% |
| Q3 2015 | $20,481,000 | -7.6% | 2,423,776 | +19.7% | 0.01% | 0.0% |
| Q2 2015 | $22,169,000 | -20.4% | 2,024,524 | +1.6% | 0.01% | -14.3% |
| Q1 2015 | $27,852,000 | -11.1% | 1,992,353 | +7.4% | 0.01% | -12.5% |
| Q4 2014 | $31,322,000 | +32.4% | 1,854,495 | +5.2% | 0.01% | +14.3% |
| Q3 2014 | $23,660,000 | +3.9% | 1,763,011 | -1.4% | 0.01% | +16.7% |
| Q2 2014 | $22,775,000 | +21.4% | 1,787,776 | +13.3% | 0.01% | +20.0% |
| Q1 2014 | $18,764,000 | -30.8% | 1,578,150 | -19.6% | 0.01% | -37.5% |
| Q4 2013 | $27,122,000 | -8.6% | 1,964,000 | +15.5% | 0.01% | -11.1% |
| Q3 2013 | $29,675,000 | -9.0% | 1,700,549 | -15.2% | 0.01% | -18.2% |
| Q2 2013 | $32,597,000 | – | 2,005,990 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
| Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
| Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
| PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
| Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
| ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |